Figure INF-9:  Prevalence of HCV current infection and HCV genotypes among injecting drug users, where data available – Part (i) Percentage RNA positive and percentage HCV antibody positive injecting drug users

Notes:

See 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Adapted from Matheï, C., Buntinx, F. & Damme, P. Van (2002). Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. Journal of Viral Hepatitis 9 (3), 157-173.

Data filter | inffig09a-en.xml